Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Names NCGR Certified Service Provider

NEW YORK (GenomeWeb News) – Agilent Technologies today announced the National Center for Genome Resources as a Certified Service Provider for the company's SureSelect Target Enrichment System for next-generation sequencing.

NCGR, based in Santa Fe, NM, now provides Agilent exome and custom target enrichment services along with sequencing and analysis for genomics research. The facility offers sequencing services on Illumina and Pacific Biosciences platforms. Its services, as well as collaborations it has, cover cancer, infectious diseases, inherited childhood diseases, legume biology, crop improvement, and population genetics.

"Achieving CSP status is an important step, allowing us to expand our sequencing menu to offer enrichment of genomic regions in conjunction with next-gen sequencing, a service for which there is growing demand," Callum Bell, NCGR's vice president for research, said in a statement.

NCGR participated in comprehensive on-site training and passed a set of requirements demonstrating expertise and skill in order to attain CSP status, said Agilent.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.